Sionna Therapeutics, Inc. (SION)
35.49
-1.85
(-4.95%)
USD |
NASDAQ |
Feb 20, 16:00
35.54
+0.05
(+0.14%)
Pre-Market: 20:00
Sionna Therapeutics Shareholders Equity (Quarterly) : 321.67M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | 130.60M |
| Spruce Biosciences, Inc. | 5.386M |
| Atai Beckley, Inc. | 159.75M |
| Septerna, Inc. | 388.73M |
| Aardvark Therapeutics, Inc. | 122.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 339.27M |
| Total Liabilities (Quarterly) | 17.60M |
| Debt to Equity Ratio | 0.0279 |
| Current Ratio | 25.61 |
| Net Debt Paydown Yield | -0.14% |